← signals
2026-07-19·NVDA·pricing change
meddown

Nvidia's planned RTX 50 Super GPU refresh is reportedly on hold because of the high cost of 3GB GDDR7 memory modules.

Nvidia's planned RTX 50 Super GPU refresh is reportedly on hold because of the high cost of 3GB GDDR7 memory modules.

window 60devidence 32confidence score 100price NVDA $207.40

confidence score

Strong evidence: 4 independent source classes support this read.

100
medium confidence4 independent source classesdeveloperofficialnewsmarketpasses publish gate
priced-in check

NVDA has not made a large direction-matching 30-90 day move yet.

not priced in
as of 2026-07-167d n/a45d n/a90d +3%yahoo

signal brief

Nvidia's planned RTX 50 Super GPU refresh is reportedly on hold because of the high cost of 3GB GDDR7 memory modules. According to Tom's Hardware, citing a VideoCardz source, board partners have already received GPU dies, but Nvidia has told them the products are stalled due to memory pricing. The 3GB GDDR7 chips cost two to three times as much as 2GB variants, pushing retail prices above Nvidia's target MSRP and threatening partner margins. This memory cost crisis has also affected Nvidia's datacenter business, where memory now accounts for 25% of BOM, a nearly 500% cost increase. The delay marks the first time in five years Nvidia has not announced a new GPU at CES, underscoring the severity of the supply chain strain. The RTX 5080 Super, 5070 Ti Super, 5070 Super, and 5050 are the affected models. While Nvidia's AI GPU business remains dominant, the consumer segment faces headwinds that could signal broader pricing pressure across the company's product lines.

What the sources said:

  • "these chips cost twice or thrice as much as their 2GB variants" (source 4)
  • "memory accounting for 25% of the BOM, as costs have soared by nearly 500%" (source 4)
  • "Nvidia has allegedly told the company that the products are on hold because of the price of 3GB GDDR7 memory chips" (source 4)

source data used

spillover entities

Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.